Heparine Natrium B. Braun

Heparine Natrium B. Braun is a pharmaceutical product that contains the active ingredient heparin sodium. It is supplied as an injectable solution for intravenous administration, with the specific strength not disclosed in the available data. Classified as an anticoagulant and antithrombotic, this prescription‑only medication is marketed in the European Union and is used under medical supervision to manage clot‑related conditions.

Heparine Natrium B. Braun is indicated for several clinical situations where anticoagulation is required. It is commonly employed in the prevention and treatment of venous thromboembolic events.

- Prevention of venous thromboembolism in postoperative or immobilized patients - Treatment of acute deep vein thrombosis (DVT) - Management of pulmonary embolism (PE) - Anticoagulation during cardiac surgery, including cardiopulmonary bypass - Anticoagulation for patients undergoing hemodialysis or other extracorporeal circuits

Heparine Natrium B. Braun may cause a range of adverse reactions, most of which are related to its anticoagulant activity.

Common: - Minor bleeding at injection site - Hematuria (blood in urine) - Epistaxis (nosebleeds) - Gastrointestinal irritation or mild abdominal discomfort - Elevated liver enzymes (transient)

Serious: - Major hemorrhage (intracranial, gastrointestinal, or surgical site) - Heparin‑induced thrombocytopenia (HIT) - Allergic reactions including anaphylaxis - Spontaneous spinal or epidural hematoma

Before initiating therapy with Heparine Natrium B. Braun, clinicians should evaluate patient‑specific risk factors and monitor relevant parameters.

- Assess baseline coagulation status (aPTT, PT/INR) and platelet count - Review history of bleeding disorders, recent surgery, or trauma - Use caution in patients with renal or hepatic impairment - Avoid use in individuals with known hypersensitivity to heparin or pork products - Monitor for signs of heparin‑induced thrombocytopenia during treatment - Adjust dose or discontinue if uncontrolled bleeding occurs

Heparine Natrium B. Braun can interact with other agents that affect hemostasis or platelet function.

Avoid: - Concurrent use of other anticoagulants (e.g., warfarin, direct oral anticoagulants) without close monitoring - Thrombolytic agents (e.g., alteplase, streptokinase) - High‑dose aspirin or non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase bleeding risk

Use with caution: - Antiplatelet drugs such as clopidogrel or dipyridamole - Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents - Glycoprotein IIb/IIIa inhibitors - Certain antibiotics (e.g., cefotetan) that may potentiate anticoagulant effect